Publications

5808 Results

Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial. PMID21335507; PMC3070045

Authors
A Kristal;C Till;E Platz;X Song;I King;M Neuhouser;C Ambrosone;IM Thompson
Journal / Conference
Cancer Epidemiology Biomarkers Prevention 20(4):638-646
Year
2011
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Finasteride reduces the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial

Authors
JK Parsons;J Schenk;K Arnold;K Messer;C Till;IM Thompson;A Kristal
Journal / Conference
AUA Annual Meeting, accepted, oral, late-breaking
Year
2011
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

SWOG S0215: A phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast [PMID21826527;PMC3513946]

Authors
R Livingston;W Barlow;J Kash;K Albain;J Gralow;D Lew;L Flaherty;ME Royce;GN Hortobagyi
Journal / Conference
Breast Cancer Research and Treatment 130(1):123-131;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S0215

Measuring the performance of markers for guiding treatment decisions [PMID21320940; PMC3085402]

Authors
H Janes;J Pepe;W Barlow
Journal / Conference
Annals of Internal Medicine 154(4):253-259, 2011
Year
2011
Research Committee(s)
Multiple sites

C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the North Central Cancer Treatment Group N9831 adjuvant trastuzumab trial [PMID21245420; PMC3056653]

Authors
EA Perez;RB Jenkins;AC Dueck;AE Wiktor;PP Bedroske;SK Anderson;RP Kettering;WR Sukow;K Kanehira;B Chen;XJ Geiger;CA Andorfer;AE McCullough;N Davidson;S Martino;GW Sledge;PA Kaufman;LA Kutteh;J Gralow;LN Harris;JN Ingle;WL Lingle;MM Reinholz
Journal / Conference
Journal of Clinical Oncology 29(6):651-659
Year
2011
Research Committee(s)
Breast
Study Number(s)
N9831

High-dose chemotherapy with autologous stem cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials [PMID21768471]

Authors
DA Berry;NT Ueno;MM Johnson;X Lei;J Caputo;S Rodenhuis;W Peters;RC Leonard;WE Barlow;M Tallman;J Bergh;NA Nitz;AM Gianni;RL Basser;A Zander;RC Coombes;H Roche;Y Tokuda;E de Vries;G Hortobagyi;JP Crown;P Pedrazzoli;M Bregni;T Demirer
Journal / Conference
Journal of Clinical Oncology 29(24):3214-3223;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S9623

Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype [PMID21330329; PMC3069244]

Authors
B Xie;M Othus;B Medeiros;M Fang;F Appelbaum;E Estey
Journal / Conference
Haematologica 96(4):631-632
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918

Association of excision repair cross- comple-mentation Group 1 (ERCC1) gene expression (GE) with outcome in stage II-III esophageal adenocarcinoma (EA) patients treated with preoperative platinum-based chemoradiation (CRT) in a phase II cooperative group study (SWOG S0356)

Authors
PO Bohanes;B Goldman;L Leichman;CD Blanke;S Iqbal;CR Thomas;C Corless;KG Billingsley;KD Danenberg;W Zhang;J Benedetti;PJ Gold;HJ Lenz
Journal / Conference
Journal of Clinical Oncology 29: 2011 (suppl; abstr 4023); American Society of Clinical Oncology 2011 meeting, poster discussion;
Year
2011
Research Committee(s)
Gastrointestinal
Study Number(s)
S0356

Incorporating comparative effectiveness research study endpoints into the treatment for positive node, endocrine responsive breast cancer (RxPonder) study

Authors
SD Ramsey;WE Barlow;C Moinpour;A Gonzalez-Angulo;G Hortobagyi;D Veenstra;L Garrison;SR Tunis;LH Baker
Journal / Conference
Journal of Clinical Oncology 29:(suppl; abstr TPS101); ASCO Annual 2011 Meeting, poster presentation.
Year
2011
Research Committee(s)
Breast
Study Number(s)
S1007

Interim report of on-study demographics and toxicity from Eastern Cooperative Oncology Group (ECOG) E1505, a phase III randomized trial of adjuvant chemotherapy with or without bevacizumab for completely resected early stage non-small cell lung cancer (NSCLC)

Authors
H Wakelee;S Dahlberg;S Keller;DR Gandara;S Graziano;N Leigh;A Adjei;J Schiller
Journal / Conference
J Thorac Oncol. 2011; 6(6)(suppl 2): S464. abstract 042.03; IASLC, 14th World Conference on Lung Cancer, oral presentation;
Year
2011
Research Committee(s)
Lung
Study Number(s)
CTSU/E1505